Vascular Depression

  • Alan J. Thomas
Part of the Neuropsychiatric Symptoms of Neurological Disease book series (NSND)


The “vascular depression” hypothesis postulates that cerebral ischaemic damage to frontal-subcortical circuits predisposes to and/or perpetuates depression in older people, but this concept has been criticized because community studies have failed to demonstrate a robust relationship between depression and vascular disease and because of the apparent inability to define the clinical entity of “vascular depression.” However, evidence clearly demonstrates that depression has a bidirectional relationship with vascular disease (Thomas et al., J Affect Disord 79(1–3):81–95, 2004) and that there is an increase in late-life depression in MRI WMH, which are ischaemic lesions. The explanation for the differences in these findings probably reflects the insensitivity of (peripherally measured) conventional VRFs for actual ischaemic disease in the brain and the differences in samples, with the MRI and pathology studies assessing major depression in secondary care patients while the community studies sample milder cases of depression and one’s which may have a different aetiology. More recent evidence supports a definition of “vascular depression” focusing on a subgroup defined by the burden of WMH and indicates such a subgroup is both robust and clinically important in that it appears to predict poor response to treatment, persistence of depressive symptoms and of neurocognitive impairments, and worse longer-term outcomes.


Depression Late life Vascular Cerebrovascular disease MRI White matter hyperintensities 


  1. 1.
    Almeida OP. Vascular depression: myth or reality? Int Psychogeriatr. 2008;20(4):645–52.PubMedCrossRefGoogle Scholar
  2. 2.
    Kim JM, Stewart R, Shin IS, Yoon JS. Vascular disease/risk and late-life depression in a Korean community population. Br J Psychiatry. 2004;185:102–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Lyness JM, Caine ED, Cox C, King DA, Conwell Y, Olivares T. Cerebrovascular risk factors and later-life major depression. Testing a small-vessel brain disease model. Am J Geriatr Psychiatry. 1998;6(1):5–13.PubMedGoogle Scholar
  4. 4.
    Lyness JM, Caine ED, King DA, Conwell Y, Cox C, Duberstein PR. Cerebrovascular risk factors and depression in older primary care patients: testing a vascular brain disease model of depression. Am J Geriatr Psychiatry. 1999;7(3):252–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Naarding P, Tiemeier H, Breteler MMB, Schoevers RA, Jonker C, Koudstaal PJ, et al. Clinically defined vascular depression in the general population. Psychol Med. 2007;37(3):383–92.PubMedCrossRefGoogle Scholar
  6. 6.
    Kim J-M, Stewart R, Kim S-W, Yang S-J, Shin I-S, Yoon J-S. Vascular risk factors and incident late-life depression in a Korean population. Br J Psychiatry. 2006;189:26–30.PubMedCrossRefGoogle Scholar
  7. 7.
    Lyness JM, King DA, Conwell Y, Cox C, Caine ED. Cerebrovascular risk factors and 1-year depression outcome in older primary care patients. Am J Psychiatry. 2000;157(9):1499–501.PubMedCrossRefGoogle Scholar
  8. 8.
    Richardson J, Kerr SRJ, Shaw F, Kenny RA, O’Brien JT, Thomas AJ. A study of orthostatic hypotension in late-life depression. Am J Geriatr Psychiatry. 2009;17(11):996–9. doi: 10.1097/JGP.0b013e3181b4bf35.PubMedCrossRefGoogle Scholar
  9. 9.
    Vasudev A, O’Brien JT, Tan MP, Parry SW, Thomas AJ. A study of orthostatic hypotension, heart rate variability and baroreflex sensitivity in late-life depression. J Affect Disord. 2011;131:374–8 (Epub 2010/12/03).PubMedCrossRefGoogle Scholar
  10. 10.
    Thomas AJ, Kalaria RN, O’Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord. 2004;79(1–3):81–95.PubMedCrossRefGoogle Scholar
  11. 11.
    Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med. 1998;158(13):1422–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation. 1996;94(12):3123–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med. 2000;62(4):463–71.PubMedGoogle Scholar
  14. 14.
    Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen A-H, Brady SM, Kase CS, et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke. 2007;38(1):16–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Herrmann LL, Le Masurier M, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008;79(6):619–24.PubMedCrossRefGoogle Scholar
  16. 16.
    Sheline YI, Price JL, Vaishnavi SN, Mintun MA, Barch DM, Epstein AA, et al. Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry. 2008;165(4):524–32.PubMedCrossRefGoogle Scholar
  17. 17.
    Thomas AJ, O’Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry. 2002;59(9):785–92.PubMedCrossRefGoogle Scholar
  18. 18.
    Thomas AJ, Perry R, Kalaria RN, Oakley A, McMeekin W, O’Brien JT. Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression. Int J Geriatr Psychiatry. 2003;18(1):7–13.PubMedCrossRefGoogle Scholar
  19. 19.
    Thomas AJ, O’Brien JT, Barber R, McMeekin W, Perry R. A neuropathological study of periventricular white matter hyperintensities in major depression. J Affect Disord. 2003;76:49–54.PubMedCrossRefGoogle Scholar
  20. 20.
    Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22(3):312–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Colloby SJ, Vasudev A, et al. Relationship of orthostatic blood pressure to white matter hyperintensities and subcortical volumes in late-life depression. Br J Psychiatry. 2011;199:404–10.Google Scholar
  22. 22.
    Krishnan MS, O’Brien JT, Firbank MJ, Pantoni L, Carlucci G, Erkinjuntti T, et al. Relationship between periventricular and deep white matter lesions and depressive symptoms in older people: the LADIS Study. Int J Geriatr Psychiatry. 2006;21:983–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A, et al. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med. 2010;40(4):603–10.PubMedCrossRefGoogle Scholar
  24. 24.
    Teodorczuk A, O’Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, et al. White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry. 2007;191:212–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Steffens DC, Krishnan KRR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke. 2002;33(6):1636–44.PubMedCrossRefGoogle Scholar
  26. 26.
    Godin O, Dufouil C, Maillard P, Delcroix N, Mazoyer B, Crivello F, et al. White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol Psychiatry. 2008;63(7):663–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Kohler S, Thomas AJ, Barnett NA, O’Brien JT. The pattern and course of cognitive impairment in late-life depression. Psychol Med. 2010;40(4):591–602.PubMedCrossRefGoogle Scholar
  28. 28.
    Kramer-Ginsberg E, Greenwald BS, Krishnan KR, Christiansen B, Hu J, Ashtari M, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. Am J Psychiatry. 1999;156(3):438–44.PubMedGoogle Scholar
  29. 29.
    Kohler S, Thomas AJ, Lloyd A, Barber R, Almeida OP, O’Brien JT. White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. Br J Psychiatry. 2010;196(2):143–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Simpson S, Baldwin RC, Jackson A, Burns AS. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late life depression. Psychol Med. 1998;28:1015–26.PubMedCrossRefGoogle Scholar
  31. 31.
    Taylor WD, Steffens DC, MacFall JR, McQuoid DR, Payne ME, Provenzale JM, et al. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry. 2003;60(11):1090–6.PubMedCrossRefGoogle Scholar
  32. 32.
    O’Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ. 1998;317(7164):982–4.PubMedCrossRefGoogle Scholar
  33. 33.
    Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M-P, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37:151–60.PubMedCrossRefGoogle Scholar
  34. 34.
    Taylor WD, MacFall JR, Payne ME, McQuoid DR, Provenzale JM, Steffens DC, et al. Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter. Am J Psychiatry. 2004;161(7):1293–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Thomas AJ, Ferrier IN, Kalaria RN, Davis S, O’Brien JT. Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly. Br J Psychiatry. 2002;181:129–34.PubMedGoogle Scholar
  36. 36.
    Alexopoulos GS, Kiosses DN, Choi SJ, Murphy CF, Lim KO. Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry. 2002;159(11):1929–32.PubMedCrossRefGoogle Scholar
  37. 37.
    Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, et al. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry. 2008;165(2):238–44.PubMedCrossRefGoogle Scholar
  38. 38.
    Alexopoulos GS, Meyers BS, et al. Vascular depression hypothesis. Arch Gen Psychiatry. 1997;54(10):915–92.PubMedCrossRefGoogle Scholar
  39. 39.
    Sneed JR, Rindskopf D, Steffens DC, Krishnan KRR, Roose SP. The vascular depression subtype: evidence of internal validity. Biol Psychiatry. 2008;64(6):491–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of “vascular depression”. Int J Geriatr Psychiatry. 2001;16(3):254–60.PubMedCrossRefGoogle Scholar
  41. 41.
    Taragano FE, Bagnatti P, Allegri RF. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of “vascular depression”. Int Psychogeriatr. 2005;17(3):487–98.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Institute for Ageing and HealthNewcastle University, Campus for Ageing and VitalityNewcastle upon TyneUK

Personalised recommendations